REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
HPLE EXCIPIENTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
HPLE EXCIPIENTS
ST13
US500000087608792Class
1, 42
Filing
87608792
Registration
6257475
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/27/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 42
Filing date
09/14/2017
Registration date
01/26/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2020
First use in commerce
05/01/2020
Drawing code
4
Owner type
03
Owner location
Waukegan, IL
Examiner
GULIANO, ROBERT N
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pfanstiehl, Inc.
Representatives
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
Class 42
Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/23/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/02/2020
GNRT
NON-FINAL ACTION E-MAILED
10/02/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/14/2020
EX4G
SOU EXTENSION 4 GRANTED
09/14/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/14/2020
IUAF
USE AMENDMENT FILED
08/28/2020
EXT4
SOU EXTENSION 4 FILED
08/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/28/2020
EISU
TEAS STATEMENT OF USE RECEIVED
08/24/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2020
EX3G
SOU EXTENSION 3 GRANTED
02/25/2020
EXT3
SOU EXTENSION 3 FILED
02/25/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/25/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/29/2019
EX2G
SOU EXTENSION 2 GRANTED
08/27/2019
EXT2
SOU EXTENSION 2 FILED
08/27/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/27/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2019
EX1G
SOU EXTENSION 1 GRANTED
02/25/2019
EXT1
SOU EXTENSION 1 FILED
02/25/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/25/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/28/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/03/2018
PUBO
PUBLISHED FOR OPPOSITION
07/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/13/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/29/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
11/22/2017
GPRA
PRIORITY ACTION E-MAILED
11/22/2017
CPRA
PRIORITY ACTION WRITTEN
11/22/2017
DOCK
ASSIGNED TO EXAMINER
11/18/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/20/2017
NWAP
NEW APPLICATION ENTERED
09/18/2017
Continuous trademark protection
Get notified about every new filing that threatens HPLE EXCIPIENTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.